COVID-19 Impact on Global Amyotrophic Lateral Sclerosis Therapeutics Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: C4152E56EAC9EN
QYResearch

Abstracts

This report focuses on the global Amyotrophic Lateral Sclerosis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Amyotrophic Lateral Sclerosis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Mitsubishi Tanabe Pharma
• Sanofi
• Mylan Pharma
• Apotex
• Glemark Generics
• Covis Pharma
• Sun Pharma
• Lunan Pharma

Market segment by Type, the product can be split into

• Riluzole
• Edaravone (Radicava)
• Other

Market segment by Application, split into

• Hospital
• Drugs Store
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Amyotrophic Lateral Sclerosis Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Amyotrophic Lateral Sclerosis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Amyotrophic Lateral Sclerosis Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Riluzole
  1.4.3 Edaravone (Radicava)
  1.4.4 Other
1.5 Market by Application
  1.5.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Drugs Store
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Amyotrophic Lateral Sclerosis Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Amyotrophic Lateral Sclerosis Therapeutics Industry
    1.6.1.1 Amyotrophic Lateral Sclerosis Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Amyotrophic Lateral Sclerosis Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Amyotrophic Lateral Sclerosis Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Amyotrophic Lateral Sclerosis Therapeutics Market Perspective (2015-2026)
2.2 Amyotrophic Lateral Sclerosis Therapeutics Growth Trends by Regions
  2.2.1 Amyotrophic Lateral Sclerosis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Amyotrophic Lateral Sclerosis Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Amyotrophic Lateral Sclerosis Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Amyotrophic Lateral Sclerosis Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Market Size
  3.1.1 Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Amyotrophic Lateral Sclerosis Therapeutics Market Concentration Ratio
  3.2.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Therapeutics Revenue in 2019
3.3 Amyotrophic Lateral Sclerosis Therapeutics Key Players Head office and Area Served
3.4 Key Players Amyotrophic Lateral Sclerosis Therapeutics Product Solution and Service
3.5 Date of Enter into Amyotrophic Lateral Sclerosis Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Amyotrophic Lateral Sclerosis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Type (2021-2026)

5 AMYOTROPHIC LATERAL SCLEROSIS THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020)
5.2 Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size (2015-2020)
6.2 Amyotrophic Lateral Sclerosis Therapeutics Key Players in North America (2019-2020)
6.3 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020)
6.4 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size (2015-2020)
7.2 Amyotrophic Lateral Sclerosis Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020)
7.4 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Amyotrophic Lateral Sclerosis Therapeutics Market Size (2015-2020)
8.2 Amyotrophic Lateral Sclerosis Therapeutics Key Players in China (2019-2020)
8.3 China Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020)
8.4 China Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size (2015-2020)
9.2 Amyotrophic Lateral Sclerosis Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020)
9.4 Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size (2015-2020)
10.2 Amyotrophic Lateral Sclerosis Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Amyotrophic Lateral Sclerosis Therapeutics Market Size (2015-2020)
11.2 Amyotrophic Lateral Sclerosis Therapeutics Key Players in India (2019-2020)
11.3 India Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020)
11.4 India Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Amyotrophic Lateral Sclerosis Therapeutics Market Size (2015-2020)
12.2 Amyotrophic Lateral Sclerosis Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Mitsubishi Tanabe Pharma
  13.1.1 Mitsubishi Tanabe Pharma Company Details
  13.1.2 Mitsubishi Tanabe Pharma Business Overview and Its Total Revenue
  13.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
  13.1.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020))
  13.1.5 Mitsubishi Tanabe Pharma Recent Development
13.2 Sanofi
  13.2.1 Sanofi Company Details
  13.2.2 Sanofi Business Overview and Its Total Revenue
  13.2.3 Sanofi Amyotrophic Lateral Sclerosis Therapeutics Introduction
  13.2.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
  13.2.5 Sanofi Recent Development
13.3 Mylan Pharma
  13.3.1 Mylan Pharma Company Details
  13.3.2 Mylan Pharma Business Overview and Its Total Revenue
  13.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
  13.3.4 Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
  13.3.5 Mylan Pharma Recent Development
13.4 Apotex
  13.4.1 Apotex Company Details
  13.4.2 Apotex Business Overview and Its Total Revenue
  13.4.3 Apotex Amyotrophic Lateral Sclerosis Therapeutics Introduction
  13.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
  13.4.5 Apotex Recent Development
13.5 Glemark Generics
  13.5.1 Glemark Generics Company Details
  13.5.2 Glemark Generics Business Overview and Its Total Revenue
  13.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Introduction
  13.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
  13.5.5 Glemark Generics Recent Development
13.6 Covis Pharma
  13.6.1 Covis Pharma Company Details
  13.6.2 Covis Pharma Business Overview and Its Total Revenue
  13.6.3 Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
  13.6.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
  13.6.5 Covis Pharma Recent Development
13.7 Sun Pharma
  13.7.1 Sun Pharma Company Details
  13.7.2 Sun Pharma Business Overview and Its Total Revenue
  13.7.3 Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
  13.7.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
  13.7.5 Sun Pharma Recent Development
13.8 Lunan Pharma
  13.8.1 Lunan Pharma Company Details
  13.8.2 Lunan Pharma Business Overview and Its Total Revenue
  13.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
  13.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
  13.8.5 Lunan Pharma Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Amyotrophic Lateral Sclerosis Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Amyotrophic Lateral Sclerosis Therapeutics Revenue
Table 3. Ranking of Global Top Amyotrophic Lateral Sclerosis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Riluzole
Table 6. Key Players of Edaravone (Radicava)
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Amyotrophic Lateral Sclerosis Therapeutics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Amyotrophic Lateral Sclerosis Therapeutics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Amyotrophic Lateral Sclerosis Therapeutics Players to Combat Covid-19 Impact
Table 13. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Amyotrophic Lateral Sclerosis Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Amyotrophic Lateral Sclerosis Therapeutics Players
Table 24. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis Therapeutics as of 2019)
Table 27. Global Amyotrophic Lateral Sclerosis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Amyotrophic Lateral Sclerosis Therapeutics Product Solution and Service
Table 30. Date of Enter into Amyotrophic Lateral Sclerosis Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Amyotrophic Lateral Sclerosis Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Amyotrophic Lateral Sclerosis Therapeutics Market Share (2019-2020)
Table 40. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2015-2020)
Table 42. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Amyotrophic Lateral Sclerosis Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Amyotrophic Lateral Sclerosis Therapeutics Market Share (2019-2020)
Table 46. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Amyotrophic Lateral Sclerosis Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Amyotrophic Lateral Sclerosis Therapeutics Market Share (2019-2020)
Table 52. China Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2015-2020)
Table 54. China Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Amyotrophic Lateral Sclerosis Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Amyotrophic Lateral Sclerosis Therapeutics Market Share (2019-2020)
Table 58. Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Amyotrophic Lateral Sclerosis Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Amyotrophic Lateral Sclerosis Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Amyotrophic Lateral Sclerosis Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Amyotrophic Lateral Sclerosis Therapeutics Market Share (2019-2020)
Table 70. India Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2015-2020)
Table 72. India Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Amyotrophic Lateral Sclerosis Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Amyotrophic Lateral Sclerosis Therapeutics Market Share (2019-2020)
Table 76. Central & South America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2015-2020)
Table 80. Mitsubishi Tanabe Pharma Company Details
Table 81. Mitsubishi Tanabe Pharma Business Overview
Table 82. Mitsubishi Tanabe Pharma Product
Table 83. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020) (Million US$)
Table 84. Mitsubishi Tanabe Pharma Recent Development
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Product
Table 88. Sanofi Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020) (Million US$)
Table 89. Sanofi Recent Development
Table 90. Mylan Pharma Company Details
Table 91. Mylan Pharma Business Overview
Table 92. Mylan Pharma Product
Table 93. Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020) (Million US$)
Table 94. Mylan Pharma Recent Development
Table 95. Apotex Company Details
Table 96. Apotex Business Overview
Table 97. Apotex Product
Table 98. Apotex Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020) (Million US$)
Table 99. Apotex Recent Development
Table 100. Glemark Generics Company Details
Table 101. Glemark Generics Business Overview
Table 102. Glemark Generics Product
Table 103. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020) (Million US$)
Table 104. Glemark Generics Recent Development
Table 105. Covis Pharma Company Details
Table 106. Covis Pharma Business Overview
Table 107. Covis Pharma Product
Table 108. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020) (Million US$)
Table 109. Covis Pharma Recent Development
Table 110. Sun Pharma Company Details
Table 111. Sun Pharma Business Overview
Table 112. Sun Pharma Product
Table 113. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020) (Million US$)
Table 114. Sun Pharma Recent Development
Table 115. Lunan Pharma Business Overview
Table 116. Lunan Pharma Product
Table 117. Lunan Pharma Company Details
Table 118. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020) (Million US$)
Table 119. Lunan Pharma Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Riluzole Features
Figure 3. Edaravone (Radicava) Features
Figure 4. Other Features
Figure 5. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Drugs Store Case Studies
Figure 8. Other Case Studies
Figure 9. Amyotrophic Lateral Sclerosis Therapeutics Report Years Considered
Figure 10. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Players in 2019
Figure 15. Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Therapeutics Revenue in 2019
Figure 17. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Mitsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
Figure 26. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
Figure 28. Mylan Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Mylan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
Figure 30. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
Figure 32. Glemark Generics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
Figure 34. Covis Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
Figure 36. Sun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
Figure 38. Lunan Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2015-2020)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed